Gender differences in the metabolic syndrome and their role for cardiovascular disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing epidemiological and mechanistic concepts without reported systematic search or meta-analytic pooling
PubMed 16598526 · doi:10.1007/s00392-006-0351-5
What was done
This review synthesized epidemiological surveys and physiological evidence examining sex- and gender-specific differences in the prevalence, phenotypic components, adipose tissue distribution, and cardiovascular disease (CVD) sequelae of the metabolic syndrome.
What was found
The abstract reports several qualitative observations and single survey statistics: - Metabolic syndrome prevalence has historically been higher in men, but is increasing more rapidly in women, particularly young women. - In a referenced German survey, 40% of adults had disturbed glucose tolerance or type 2 diabetes, with undiagnosed diabetes more common in men. - Globally, impaired fasting glucose occurs more frequently in men, whereas impaired glucose tolerance is relatively more frequent in women. - Premenopausal women more often develop peripheral subcutaneous adiposity, whereas men and postmenopausal women develop central/android visceral adiposity. - Diabetes and systemic inflammation convey a relatively greater increase in cardiovascular risk in women compared to men. - No meta-analytic effect sizes, pooled risk estimates, or confidence intervals are reported in the abstract.
Why it matters
Recognizing sex differences in adipose biology, glucose dysregulation, and cardiovascular vulnerability indicates that risk assessment, diagnostic criteria, and preventive interventions may require sex-tailored approaches.
Limits
The abstract describes a narrative overview without reporting systematic search methods, inclusion/exclusion criteria, or quantitative pooled estimates. Total sample size and the number of included studies are not reported.
Cited by
- supports Up to menopause women are protected against cardiometabolic conditions and fatty liver, but after menopause disease rates accelerate and catch up to men around age 60.